The immunogenic capacity of herpes simplex virs (HSV)-infected cells and their subcellular membrane fractions was investigated by assessing the anti-HSV cytotoxic T lymphocyte (CTL) response in cultures of spleen lymphocytes from HSV-primed BALBJc mice. Methylchloranthrane-induced fibrosarcoma (Meth A) cells infected with HSV (HSV-Meth A) were fixed either with glutaraldehyde or by heating at 56 C to preserve their immunogenic competence and then used as a stimulator. Microsomes and plasma membranes were prepared from HSV-Meth A and their immunogenic activities were determined. Though the recovery of stimulatory activity in the plasma membrane fraction was half of that in the microsome fraction, the activity in the former was much more stable than in the latter and the plasma membrane fraction proved to be well qualified as an immunogen for anti-HSV CTL induction. Upon purification, the specific activity of the membrane fraction, on the basis of protein concentration, increased 43-fold.Anti-herpes simplex virus cytotoxic T lymphocytes (anti-HSV CTL) are presumed to suppress HSV growth in the early phase of infection and to prevent the secondary outgrowth of HSV in the recurrent disease (12). In fact, enhanced activity of anti-HSV CTL has been noted in post-herpetic patients (17,18,20), as well as in the animal model system of HSV infection (5, 9, 22). For induction of CTL, inoculation oflive virus has been employed widely (25), but it is not feasible to use live HSV because of the oncogenic potency of the HSV genome (1, 6). It is therefore desirable to develop a simplified artificial immunogen specific for CTL induction. To this end, the attempt to reconstitute the immunogen by using HSV antigens and histocompatible membrane antigens appears to be promising (8), as described for other virus systems (4, 7).By virtue of the method previously devised for in vitro assay of anti-HSV CTL (22), it is now feasible to identity the immunogenic molecules of HSV and the requirements of major histocompatibility complex (MHC)-related molecules. In the present study, we reevaluated the immunogenicity of HSV-infected methyl-757